The concept of prenatal gene therapy

Methods in Molecular Biology

Volumn 891, Issue , 2012, Pages 1-7

  Coutelle, Charles ^a   Waddington, Simon N ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Animal models; Ethical considerations; Fetal Medicine; Genetic disease; Prenatal (in utero, fetal) gene therapy; Prenatal disease; Prevention; Vectors

Indexed keywords

VIRUS VECTOR;

ARTICLE; CARCINOGENESIS; CONGENITAL MALFORMATION; DNA SEQUENCE; ECHOGRAPHY; EX VIVO STUDY; FETOSCOPY; FETUS DEVELOPMENT; FETUS OUTCOME; GENE SEQUENCE; GENETIC SCREENING; GESTATIONAL AGE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IN UTERO STEM CELL TRANSPLANTATION; MINIMALLY INVASIVE PROCEDURE; MOLECULAR CLONING; MOLECULAR PATHOLOGY; NONHUMAN; PATIENT SAFETY; PERINATAL PERIOD; PREMATURITY; PRENATAL CARE; PRENATAL DIAGNOSIS; PRENATAL DISORDER; PRIORITY JOURNAL; THALASSEMIA; TISSUE INJURY; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

EID: 84934434571     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-873-3_1     Document Type: Article

References (37)

1. McCandless SE, Brunger JW, Cassidy SB (2004) The burden of genetic disease on inpatient care in a children's hospital. Am J Hum Genet 74:121-127
2. Flake AW, Harrisson MR (1995) Fetal surgery. Ann Rev Med 46:67-78
3. Harrison MR (2000) Surgically correctable fetal disease. Am J Surg 180:335-342
4. Anderson W, Kantoff P, Eglitis M et al (1986) Gene transfer and expression in nonhuman primates using retroviral vectors. Cold Spring Harb Symp Quant Biol 51(Pt 2):1073-1081
5. Eglitis M, Kantoff PW, McLachlin JR et al (1987) Gene therapy: efforts at developing large animal models for autologous bone marrow transplant and gene transfer with retroviral vectors. Ciba Found Symp 130:229-246
6. Kantoff PW, Flake AW, Eglitis MA, Scharf S et al (1989) In utero gene transfer and expression: a sheep transplantation model. Blood 73: 1066-1073
7. Touraine JL (1992) In-utero transplantation of fetal liver stem cells into human fetuses. Hum Reprod 7:44-48
8. Hatzoglou M, Lamers W, Bosch F et al (1990) Hepatic gene transfer in animals using retroviruses containing the promoter from the gene for phosphoenolpyruvate carboxykinase. J Biol Chem 265:17285-17293
9. Hatzoglou M, Moorman A, Lamers W (1995) Persistent expression of genes transferred in the fetal rat liver via retroviruses. Somatic Cell Mol Biol 2:265-278
10. Holzinger A, Trapnell BC, Weaver TE, Whitsett JA, Iwamoto HS (1995) Intraamniotic administration of an adenovirus vector for gene transfer to fetal sheep and mouse tissue. Pediatr Res 38:844-850
11. McCray PB, Armstrong K, Zabner J, Miller DW et al (1995) Adenoviral-mediated gene transfer to fetal pulmonary epithelia in vitro and in vivo. J Clin Invest 95:2620-2632
12. Pitt BR, Schwarz MA, Pilewski JM et al (1995) Retrovirus-mediated gene transfer in lungs of living fetal sheep. Gene Ther 2:344-350
13. Tsukamoto M, Ochiya T, Yoshida S et al (1995) Gene transfer and expression in progeny after intravenous DNA injection into pregnant mice. Nat Genet 9:243-248
14. Waddington SN, Kramer MG, Hernandez-Alcoceba R et al (2005) In utero gene therapy: current challenges and perspectives. Mol Ther 11:661-676
15. David A, Peebles D (2007) Gene therapy for the fetus: is there a future? Best Pract Res Clin Obstet Gynaecol 22:203-218
16. Waddington S, Buckley SMK, David AL et al (2007) Fetal gene transfer. Curr Opin Mol Ther 9:432-438
17. David AL, Torondel B, Zachary I et al (2008) Local delivery of VEGF adenovirus to the uterine artery increases vasorelaxation and uterine blood fl ow in the pregnant sheep. Gene Ther 15:1344-1350
18. Katz AB, Keswani SG, Habli M et al (2009) Placental gene transfer: transgene screening in mice for trophic effects on the placenta. Am J Obstet Gynecol 201(499):e491-e498
19. Laurema A, Vanamo K, Heikkila A et al (2004) Fetal membranes act as a barrier for adenoviruses: gene transfer into exocoelomic cavity of rat fetuses does not affect cells in the fetus. Am J Obstet Gynecol 190:264-267
20. Xing A, Boileau P, Cauzac M et al (2000) Comparative in vivo approaches for selective adenovirus-mediated gene delivery to the placenta. Hum Gene Ther 11:167-177
21. Senut M, Suhr ST, Gage FH (1998) Gene transfer to the rodent placenta in situ. A new strategy for delivering gene products to the fetus. Clin Invest 101:1565-1571
22. Koyama S, Kimura T, Ogita K et al (2006) Transient local overexpression of human vascular endothelial growth factor (VEGF) in mouse feto-maternal interface during mid-term pregnancy lowers systemic maternal blood pressure. Horm Metab Res 38:619-624
23. Zenclussen ML, Anegon I, Bertoja AZ et al (2006) Over-expression of heme oxygenase-1 by adenoviral gene transfer improves pregnancy outcome in a murine model of abortion. J Reprod Immunol 69:35-52
24. Coutelle C, Douar A-M, College WH, Froster U (1995) The challenge of fetal gene therapy. Nat Med 1:864-866
25. Senut M, Gage FH (1999) Prenatal gene therapy: can the technical hurdles be overcome? Mol Med Today 5:152-156
26. Porada CD, Park P, Almeida-Porada G, Zanjani ED (2004) The sheep model of in utero gene therapy. Fetal Diagn Ther 19:23-30
27. Coutelle C, Themis M, Waddington SN et al (2005) Gene therapy progress and prospects: fetal gene therapy-fi rst proofs of concept-some adverse effects. Gene Ther 12:1601-1607
28. O'Brien B, Bianchi DW (2005) Fetal therapy for single gene disorders. Clin Obstet Gynecol 48:885-896
29. Santore MT, Roybal JL, Flake AW (2009) Prenatal stem cell transplantation and gene therapy. Clin Perinatol 36:451-471, x. i.
30. David A, Themis M, Waddington S et al (2003) The current status and future direction of fetal gene therapy. Gene Ther Mol Biol 7:181-209
31. Zanjani ED, Anderson WF (1999) Prospects for in utero human gene therapy. Science 285:2084-2088
32. RAC (2000) Prenatal gene transfer: scienti fi c medical and ethical issues. A report of the Recombinant DNA Advisory Committee. Hum Gene Ther 11:1211-1229
33. Couzin J (1998) RAC confronts in utero gene therapy proposal. Science 282:27
34. Hacein-Bey-Abina S, von Kalle C, Schmidt M et al (2003) A serious adverse event after successful gene therapy for X-linked severe combined immunode fi ciency. N Engl J Med 348:255-256
35. Raper SE, Chirmule N, Lee FS et al (2003) Fatal systemic in fl ammatory response syndrome in a ornithine transcarbamylase de fi cient patient following adenoviral gene transfer. Mol Genet Metab 80:148-158
36. Li Z, Dullmann J, Schiedlmeier B et al (2002) Murine leukemia induced by retroviral gene marking. Science 296:497
37. Themis M, Waddington SN, Schmidt M et al (2005) Oncogenesis following delivery of a non-primate lentiviral gene therapy vector to fetal mice. Mol Ther 12:763-771